Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP664545.RAeMZmH2pxNP3PAfHgVs4obo1W_zDxFSjdyR9lkG8y5dU130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664545.RAeMZmH2pxNP3PAfHgVs4obo1W_zDxFSjdyR9lkG8y5dU130_provenance.
• NP582495.RAmmYDWxcO8oDf2CnpZnNZujd46rb7LKO0-ih5tWVhcgk130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582495.RAmmYDWxcO8oDf2CnpZnNZujd46rb7LKO0-ih5tWVhcgk130_provenance.
• NP411850.RAd9tnbRVSxmMRRnUjCmOjuIkS6T1lNoaZ9Y1eU_NSr5E130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411850.RAd9tnbRVSxmMRRnUjCmOjuIkS6T1lNoaZ9Y1eU_NSr5E130_provenance.
• NP935192.RAqQNS7vChW9nbayB-VkOjE-T2vziixZQ5L14ZQSq1zQs130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935192.RAqQNS7vChW9nbayB-VkOjE-T2vziixZQ5L14ZQSq1zQs130_provenance.
• NP414484.RALZ2pYM5AkJ3smhEqnfgHXR5YrxZrkIc5h3v6xtS3SkM130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414484.RALZ2pYM5AkJ3smhEqnfgHXR5YrxZrkIc5h3v6xtS3SkM130_provenance.
• assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP400644.RAKMi3Ql7XvKAeDruzSRE6bCK31FGaMJuYRdA4Pxc79I8130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400644.RAKMi3Ql7XvKAeDruzSRE6bCK31FGaMJuYRdA4Pxc79I8130_provenance.
• NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance.
• NP933314.RA4agfLFDR6c9R6pWN-NyjBHu9zIRYc6RIo676o-1Zhds130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933314.RA4agfLFDR6c9R6pWN-NyjBHu9zIRYc6RIo676o-1Zhds130_provenance.
• NP400639.RATKs3D8mMjd_fzDU_Sk_atuFWCsKqYgBLi3KbOfC7tQI130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400639.RATKs3D8mMjd_fzDU_Sk_atuFWCsKqYgBLi3KbOfC7tQI130_provenance.
• NP400762.RAX_dljlbbLEGWlyUdMaRhDS6u-R-HQ5zDw1jGHv_B8io130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400762.RAX_dljlbbLEGWlyUdMaRhDS6u-R-HQ5zDw1jGHv_B8io130_provenance.
• NP875042.RA7_gYJ8WrCi-EF3bh_wty4VvE_mrVIaQ6dqRaq86lSlY130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875042.RA7_gYJ8WrCi-EF3bh_wty4VvE_mrVIaQ6dqRaq86lSlY130_provenance.
• NP783135.RARtLrjtV3rng1NHlU1fI8jfosCHfj95hv-ERHhzdqgcM130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783135.RARtLrjtV3rng1NHlU1fI8jfosCHfj95hv-ERHhzdqgcM130_provenance.
• NP783153.RAbijb9B9UK_P5QgDXR0h1vtgkuiTGpOwcXHxJIrJtfNQ130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783153.RAbijb9B9UK_P5QgDXR0h1vtgkuiTGpOwcXHxJIrJtfNQ130_provenance.
• NP665160.RAGqWEyTVrivCA8bvoWIegHwfX7o7mulfpSbOT8LzKcuA130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665160.RAGqWEyTVrivCA8bvoWIegHwfX7o7mulfpSbOT8LzKcuA130_provenance.
• assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_provenance.
• NP890282.RAAw2BHZzTFWlex4Bs4yAY3D1GGr0A8oSxVdHOXk3CZ9I130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890282.RAAw2BHZzTFWlex4Bs4yAY3D1GGr0A8oSxVdHOXk3CZ9I130_provenance.
• NP400565.RAlbujr7CJzQyydZNgjqc-AQ7IERP_7_mwLArzaXhFwj0130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400565.RAlbujr7CJzQyydZNgjqc-AQ7IERP_7_mwLArzaXhFwj0130_provenance.
• NP890285.RAtVUup02fS8KLZcTpZtUpuMSqNt5avce41DRMiCkhYtc130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890285.RAtVUup02fS8KLZcTpZtUpuMSqNt5avce41DRMiCkhYtc130_provenance.
• NP856961.RAMg29lqlf0pPnx6L8SySGXCIbOIjkTKSGlJ1Od-RTzPs130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856961.RAMg29lqlf0pPnx6L8SySGXCIbOIjkTKSGlJ1Od-RTzPs130_provenance.
• NP400325.RA0JzzSv03_Fe4DeXkGCpwWMz8eccXifd3nGF_10VrA6Q130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400325.RA0JzzSv03_Fe4DeXkGCpwWMz8eccXifd3nGF_10VrA6Q130_provenance.
• NP783139.RAEsO0wjaA5PDNcx2B1AmDsLcwhDHLcpL0mpmFDzFtIyg130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783139.RAEsO0wjaA5PDNcx2B1AmDsLcwhDHLcpL0mpmFDzFtIyg130_provenance.
• NP890273.RAxs8rhO8WJQHLAcDKNqvRSZPCsIysHPquYdE8Ac6fs34130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890273.RAxs8rhO8WJQHLAcDKNqvRSZPCsIysHPquYdE8Ac6fs34130_provenance.
• NP890275.RAw142tpunWq87HCE3tbRIsbzTgGjH7nVTpdjZF1NCyzE130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890275.RAw142tpunWq87HCE3tbRIsbzTgGjH7nVTpdjZF1NCyzE130_provenance.
• NP890281.RA0NlGV9SJO_egOA6APtJI-IOHSRcudNBqV1vjcxmKx0I130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890281.RA0NlGV9SJO_egOA6APtJI-IOHSRcudNBqV1vjcxmKx0I130_provenance.
• NP890283.RA3aj1akdEFDI_tzEZ3wcPgiJvCSWQ7vKNH-buUo5tGt0130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890283.RA3aj1akdEFDI_tzEZ3wcPgiJvCSWQ7vKNH-buUo5tGt0130_provenance.
• NP890284.RAywvQf-u4id4AQhmupNnmfwIwineoWyo4GlgOwXzqhuw130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890284.RAywvQf-u4id4AQhmupNnmfwIwineoWyo4GlgOwXzqhuw130_provenance.